S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7229 −0.32%
CLOSED · 16:05 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
RS
INSIDER · DNTH · Dianthus Therapeutics, Inc. /DE/ · EVP, HEAD OF R&D

Randhawa Simrat

Every open-market transaction filed under this name, Sep 1 to Sep 1.

Filings
3
0 buys · 3 sells
Bought
open market, at cost
Sold
$2.5M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 1DNTHDianthus Therapeutics, Inc. /DE/EVP, Head of R&DSell13,309$106.74$1.4M
Sep 1DNTHDianthus Therapeutics, Inc. /DE/EVP, Head of R&DSell7,215$106.25$767K
Sep 1DNTHDianthus Therapeutics, Inc. /DE/EVP, Head of R&DSell2,600$105.19$273K

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.